Literature DB >> 10641967

The use of electronic mail in biomedical communication.

R Costello1, A Shaw, R Cheetham, R J Moots.   

Abstract

OBJECTIVES: To determine whether there are statistically significant differences in the content of electronic mail (e-mail) and conventional mail sent to authors of papers published in medical journals.
DESIGN: Prospective study by postal questionnaire. Over two one-month periods, corresponding authors of papers published in medical journals were asked to record details of the correspondence prompted by their publications. MEASUREMENTS: Conventional and e-mail correspondence received. Reprint requests. Content of correspondence. Quality of correspondence.
RESULTS: Eighty-two of 96 authors replied. Fifty received e-mail (mean, 5.7+/-8.8 e-mails per author) and 72 received conventional mail (15.5+/-32.8 letters per author) (p < 0.05). Seventy percent of e-mails and only 53% of correspondence sent by conventional mail (p < 0.05) referred to the content of the paper.
CONCLUSIONS: Publication in general medical journals stimulates more conventional than electronic mail. However, the content of e-mail may be of greater scientific relevance. Electronic mail can be encouraged without fear of diminishing the quality of the communications received.

Mesh:

Year:  2000        PMID: 10641967      PMCID: PMC61459          DOI: 10.1136/jamia.2000.0070103

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  2 in total

1.  Letters to the editor: the new order. Please respond to articles using website, email, or disk-but not paper

Authors: 
Journal:  BMJ       Date:  1998-05-09

2.  Communication in health care.

Authors:  P J Branger; J S Duisterhout
Journal:  Methods Inf Med       Date:  1995-06       Impact factor: 2.176

  2 in total
  1 in total

1.  Desiderata for personal electronic communication in clinical systems.

Authors:  Indra Neil Sarkar; Justin Starren
Journal:  J Am Med Inform Assoc       Date:  2002 May-Jun       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.